Takeda gets EU green light to keep bowel drug after Shire buy
Japan's Takeda Pharmaceutical Co Ltd will be allowed to keep a drug used to treat bowel disease because changes in the market have removed the need to sell it to allay EU antitrust concerns over last year's acquisition of Shire plc.